The Rising Threat of Nitazenes: Understanding the Nitazenes Overdose Risk in the U.S. Opioid Crisis
The opioid epidemic continues to evolve, with a new and alarming development: nitazenes overdose risk is becoming a critical concern for clinicians, public health...
Accompany Health Raises $56M to Expand Integrated Care for Low-Income Patients
Accompany Health has secured $56 million in Series A funding to expand its mission of delivering integrated care for low-income patients. Based in Bethesda,...
Behavioral Health Operator Turnbridge Pursues Sale Amid Growing Investor Interest and Market Opportunities
Turnbridge, a behavioral health provider focused on mental health and substance use disorder (SUD) treatment, is reportedly in advanced discussions regarding a mental health...
Election Year 2024: Why Substance Use Disorder Treatment is Poised for Strong Bipartisan Support and Progress
Election years often bring uncertainty and turbulence for many sectors, especially in behavioral health. Shifts in political power can change policy priorities, disrupt momentum...
Injectable Buprenorphine Treatment: Expanding Access to a Life-Saving Therapy
The opioid epidemic continues to devastate communities across the United States, claiming more than 100,000 lives annually. In the fight against this crisis, medications...
Behavioral Health Dealmaking in Q4 2023: A Year of Slowdowns but Growing Venture Capital Momentum
The behavioral health sector experienced a noticeable slowdown in behavioral health dealmaking 2023, with transaction activity reaching its lowest point since 2020 during the...
